Okyanos Heart Institute’s blog provides a place where heart disease patients, their caregivers and physicians can keep up with the latest information on advancements in cell therapy treatment from around the globe.
DISCLAIMER: This blog provides general information and discussion about medicine, health and related subjects. The words and other content provided in this blog, and in any linked materials, are not intended and should not be construed as medical advice. If the reader or any other person has a medical concern, he or she should consult with an appropriately-licensed physician or other health care worker.
Never disregard professional medical advice or delay in seeking it because of something you have read on this blog or in any linked materials. If you think you may have a medical emergency, call your doctor or emergency services immediately.
Inflammation is the body’s natural response to healing—a function you can probably recall from the last time you sprained your ankle or had a bad cut. The influx of white blood cells and other healing factors that are sent to an injured part of the body can produce redness and swelling as a by-product. Specific …view »
We are very pleased to have recently announced the completion of our investment funding. Since our founding in 2011, the Okyanos family has grown to include life-long friends, investors, supporters, researchers and members of the cardiology community—all of whom share our purpose and commitment towards improving the quality of life heart patients. With the success of …view »
Dr. Walpole’s article, “Options for Stem Cell Delivery in Cardiology,” was recently published in the March 2014 edition of the Cath Lab Digest. “The goal of stem cell therapy in any organ system is to deliver the best cells to the best place at the best time for the best duration to achieve the best patient …view »
The Okyanos team is abuzz with excitement on many fronts after a very successful 3-day International Stem Cell Society (STEMSO) Conference last week (February 20-22, 2014) in Freeport, Grand Bahama. The agenda, which was packed with stem cell therapy heavyweights, medical scientists and regulatory experts, kept us on our toes, learning each day about what …view »
DISCLAIMER: Opinions expressed in this blog are not necessarily those of Okyanos Heart Institute. Information herein and any included links are not endorsements or recommendations. The content may not and should not be used or relied upon for any other purpose than information, and is not intended to be the basis of medical decisions which …view »
Research has shown us the potential of stem cells to differentiate into heart cells, liver tissue, nerve cells and more. As yet, the transformation of human stem cells into working lung cells has remained uncharted territory. That is, until Columbia University researchers recently discovered the steps necessary to developing fully functional airway cells from none …view »
Without a doubt, 2013 was a big year for the advancement of stem cell research and, more specifically, cardiac care through regenerative medicine. It seemed that every month this year we heard about patients at the receiving end of cutting edge treatment, and we saw promising reports indicating that patients with conditions like lung disease, …view »
Last week, we met in Freeport for the planning of the International Stem Cell Society (STEMSO) global conference on “Bridging the Gap: Research to Point of Care.” When you’re about to have some of the world’s greatest scientists, researchers, medical practitioners, ethicists, regulators, and investors all in one place to discuss patient safety, treatment efficacy, …view »
Contributing author Matt Feshbach is Okyanos Heart Institute’s co-founder and CEO. Japan has long since been a leader in the field of medical science and research, but with the recent passage of a bill aimed at safety in the practice of regenerative medicine it would appear that the country is also global leader in stem …view »
Researchers at Lund University have taken important steps towards developing a stem cell therapy-based treatment for brain infarction, or stroke. Though still considered early-stage data, this Swedish research group hopes to be able to translate their successes thus far into clinical results which could improve the quality of life for thousands of stroke patients. What …view »